Implications of incidental findings from lung screening for primary care: data from a UK pilot

Regional lung cancer screening (LCS) is underway in England, involving a lung health check (LHC) and low-dose CT scan for those at high risk of cancer. Incidental findings from LHCs or CTs are usually referred to primary care. We describe the proportion of participants referred from the West London LCS pilot to primary care, the indications for referral, the number of general practitioner (GP) attendances and consequent changes to patient management, and provide an estimated cost-burden analysis for primary care. A small proportion (163/1542, 10.6%) of LHC attendees were referred to primary care, primarily for suspected undiagnosed chronic obstructive pulmonary disease (55/163, 33.7%) or for QRISK (R) (63/163, 38.7%) assessment. Ninety one of 159 (57.2%) participants consenting to follow-up attended GP appointments; costs incurred by primary care were estimated at 5.69 pound/LHC participant. Patient management changes occurred in only 36/159 (22.6%) referred participants. LHCs result in a small increase to primary care workload provided a strict referral protocol is adhered to. Changes to patient management arising from incidental findings referrals are infrequent.

Automated summary

Regional lung cancer screening in England involves lung health checks and low-dose CT scans for high-risk individuals. Only a small proportion of participants are referred to primary care, primarily for suspected chronic obstructive pulmonary disease or QRISK assessment. Changes in patient management resulting from these referrals are infrequent.